ArticlePharmaceutics2021

Engineered Human Heavy-Chain Ferritin with Half-Life Extension and Tumor Targeting by PAS and RGDK Peptide Functionalization.

Shuang Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.